ICMR signs MoU with FICCI for commercialization of technologies
The Federation of Indian Chambers of Commerce and Industry (FICCI) signed a MOU with Indian Council of Medical Research (ICMR) for Health Technology Accelerated Commercialization (H:TAC) Program. H:TAC will be implemented in partnership with the IC2 Institute at the University of Texas at Austin. Under the program, FICCI and IC2 Institute will commercialize technologies developed by ICMR labs for the benefit of communities at large.
The program will leverage the expertise and technical knowledge of ICMR scientists who have developed much needed affordable healthcare technologies. The program will ensure market access for the already developed technologies of ICMR labs and it would accelerate the availability of advanced diagnosis, treatment, prevention and healthcare delivery, benefitting the health and welfare of every Indian citizen.
H:TAC will also build capacities for ICMR scientists by providing them training on technology
commercialization strategies and giving them an exposure on global best practices on
innovation and commercialization. The program will take innovations from ICMR labs to not
only Indian markets but global markets by providing handholding and business development
support to ICMR scientists.
The MOU was signed in the presence of Dr. Sanjaya Baru, Secretary General, Federation of Indian Chambers of Commerce & Industry; Dr. Soumya Swaminathan, Secretary, DHR & Director General, Indian Council of Medical Research; Dr. Sanjay Madhav Mehendale, Additional Director General ICMR; Ms. Ritu Dhillon IAAS, Sr. Financial Advisor ICMR; Dr. Chandershekhar, Scientist G & Head- Innovation & Translational Research, Intellectual Property Rights, ICMR and other eminent experts of ICMR.